Emtricitabin/Tenofovirdisoproxil Al

Emtricitabine/Tenofovir Disoproxil Al is a combination medication used for HIV treatment and prevention. This oral medication helps manage HIV infection and reduce the risk of transmission.

Emtricitabine/Tenofovir Disoproxil Al is primarily used in the treatment of HIV-1 infection in adults and adolescents. It is also used for pre-exposure prophylaxis (PrEP) to prevent HIV infection in high-risk individuals. This medication works by reducing the amount of HIV in the body, helping to control the infection and improve the immune system.

Common effects of Emtricitabine/Tenofovir Disoproxil Al may include headache, nausea, diarrhea, and dizziness. Some users may also experience fatigue, insomnia, or abdominal pain. These effects vary among individuals and are not experienced by everyone.

Emtricitabine/Tenofovir Disoproxil Al should be used with caution in individuals with kidney problems or a history of bone disorders. Regular monitoring of kidney function and bone density is recommended. It is important to follow the advice of a healthcare provider regarding the use of this medication.

Emtricitabine/Tenofovir Disoproxil Al may interact with other medications, including those used to treat HIV, hepatitis B, and certain antibiotics. It is important to inform a healthcare provider about all medications being taken to avoid potential interactions. Alcohol consumption should be moderated while using this medication.